Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piera Capranzano

Showing results (21-30 of 224) with videos related to

Pageof 23
Sort By:
Evidence-Based Medicine|August 10, 2016
Transfemoral transcatheter aortic-valve replacement should be preferred over surgery in most intermediate-risk patientsCorrado Tamburino, Piera Capranzano
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 3, 2020
Balancing the expansion of transcatheter interventions for heart valve diseaseCorrado Tamburino, Piera Capranzano
Circulation. Cardiovascular Interventions|December 25, 2009
Managing patients with intermediate in-stent restenotic lesions: is it "prime time" for intravascular ultrasound imaging?Theodore A Bass, Piera Capranzano
American Heart Journal|July 31, 2008
Pharmacology of emerging novel platelet inhibitorsDominick J Angiolillo, Piera Capranzano
JACC. Cardiovascular Interventions|April 7, 2021
Antithrombotic Management of Elderly Patients With Coronary Artery DiseasePiera Capranzano, Dominick J Angiolillo
JACC. Cardiovascular Interventions|April 7, 2021
Evidence and Recommendations for Uninterrupted Versus Interrupted Oral Anticoagulation in Patients Undergoing Percutaneous Coronary InterventionPiera Capranzano, Dominick J Angiolillo
Interventional Cardiology Clinics|June 6, 2017
Basics of Antithrombotic Therapy for Cardiovascular Disease: Pharmacologic Targets of Platelet Inhibitors and AnticoagulantsPiera Capranzano, Dominick J Angiolillo
JACC. Cardiovascular Interventions|August 24, 2019
Tug of War Between Dual and Triple Antithrombotic Therapy in Atrial Fibrillation/PCI Patients With CKDPiera Capranzano, Dominick J Angiolillo
Journal of the American Heart Association|September 21, 2019
Tailoring P2Y<sub>12</sub> Inhibiting Therapy in Elderly Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionPiera Capranzano, Dominick J Angiolillo
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 10, 2019
De-escalation of oral P2Y<sub>12</sub> inhibitors guided by platelet function testing in ACS patients undergoing PCI: impact of diabetes mellitusPiera Capranzano, Dominick J Angiolillo
Pageof 23

Showing results (21-30 of 224) with videos related to

Sort By:
Pageof 23
Evidence-Based Medicine|August 10, 2016
Transfemoral transcatheter aortic-valve replacement should be preferred over surgery in most intermediate-risk patientsCorrado Tamburino, Piera Capranzano
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 3, 2020
Balancing the expansion of transcatheter interventions for heart valve diseaseCorrado Tamburino, Piera Capranzano
Circulation. Cardiovascular Interventions|December 25, 2009
Managing patients with intermediate in-stent restenotic lesions: is it "prime time" for intravascular ultrasound imaging?Theodore A Bass, Piera Capranzano
American Heart Journal|July 31, 2008
Pharmacology of emerging novel platelet inhibitorsDominick J Angiolillo, Piera Capranzano
JACC. Cardiovascular Interventions|April 7, 2021
Antithrombotic Management of Elderly Patients With Coronary Artery DiseasePiera Capranzano, Dominick J Angiolillo
JACC. Cardiovascular Interventions|April 7, 2021
Evidence and Recommendations for Uninterrupted Versus Interrupted Oral Anticoagulation in Patients Undergoing Percutaneous Coronary InterventionPiera Capranzano, Dominick J Angiolillo
Interventional Cardiology Clinics|June 6, 2017
Basics of Antithrombotic Therapy for Cardiovascular Disease: Pharmacologic Targets of Platelet Inhibitors and AnticoagulantsPiera Capranzano, Dominick J Angiolillo
JACC. Cardiovascular Interventions|August 24, 2019
Tug of War Between Dual and Triple Antithrombotic Therapy in Atrial Fibrillation/PCI Patients With CKDPiera Capranzano, Dominick J Angiolillo
Journal of the American Heart Association|September 21, 2019
Tailoring P2Y<sub>12</sub> Inhibiting Therapy in Elderly Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionPiera Capranzano, Dominick J Angiolillo
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 10, 2019
De-escalation of oral P2Y<sub>12</sub> inhibitors guided by platelet function testing in ACS patients undergoing PCI: impact of diabetes mellitusPiera Capranzano, Dominick J Angiolillo
Pageof 23